CVS’ Results Top Views as Prescription Volumes Climb; Confirms Guidance

CVS  CVS Health (NYSE: CVS – $104.04) reported net revenues for the first quarter increased 18.9%, or $6.9 billion, to $43.2 billion, compared to a year ago and $200 million above Street estimates. Revenues in the Pharmacy Services segment increased 20.5%, to $28.8 billion, primarily driven by pharmacy network claim volume and growth in specialty pharmacy. Pharmacy network claims processed during the period increased 22.6% compared to the prior year, thanks in part to net new business. Revenues in the Retail/Long-Term Care segment increased 18.6%, or $3.2 billion, to $20.1 billion, driven by the addition of the LTC operations acquired as part of the Omnicare purchase in August 2015; the addition of the pharmacies and clinics of Target Corporation acquired in December of last year; as well as pharmacy same store sales growth of 4.2% year-to-year. Adjusted earnings per share for the quarter was $1.18, two cents ahead of estimates and compared to $1.14 in 2015’s first quarter. CVS also confirmed its previous adjusted guidance for the full year and expects to deliver $5.73 to $5.88 per share, in the range the Street has for a target.

       The shares of CVS offer worthwhile 3- to 5-year price appreciation potential, especially when viewed on a risk adjusted basis. Healthy cash flow generation should enable the company to continue to take advantage of demographic trends and reward shareholders with share buybacks and dividend increases.

CVS

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: